Open contest
87 companies value 600 bn revenue 185 bn margin 10.2% free cash flow 26 bn avg. score 2.2
ABT holds 30.0% of the group's value, 1.5x the runner-up
| Rank | Ticker | Company | Share | Value | Revenue | Margin | FCF | 5 years | FCF/px | Yield | What it does · why it is here |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ABT | Abbott Laboratories United States · score 6.4 | 30% | 180 bn | 47 bn | 11.6% | 7.8 bn | 4.3% | 2.4% | Diagnostics, medical devices, nutrition and generics · Leader in continuous glucose monitoring (Libre) and diagnostics | |
| 2 | MDT | Medtronic Ireland/United States · score 6.5 | 20% | 119 bn | 38 bn | 13.9% | 6.1 bn | 5.2% | 3.1% | Medical devices: cardiac, neurological and surgical · World's largest medical device maker by revenue | |
| 3 | SYK | Stryker United States · score 6.3 | 19% | 114 bn | 26 bn | 14.4% | 4.7 bn | 4.1% | 1.1% | Orthopedic implants, surgical robotics and equipment · Leader in orthopedics and robotic surgery (Mako); consistent growth | |
| 4 | BSX | Boston Scientific United States · score 6.2 | 11% | 65 bn | 21 bn | 17.5% | 3.6 bn | 5.6% | — | Medical devices: cardiology, endoscopy and urology · Leader in interventional cardiology; fastest growth among the large players | |
| 5 | STE | STERIS Ireland · score 6.3 | 4% | 22 bn | 6.0 bn | 13.3% | 0.9 bn | 4.3% | 1.1% | Sterilization and operating room products · Hospital sterilization: practically the standard in operating rooms | |
| 6 | SOLV | Solventum United States · score 2.7 | 2% | 15 bn | 8.3 bn | 17.3% | -0.1 bn | -0.8% | — | Medical products: wound care, oral care and filtration · Wound care, monitoring and dental, spun off from 3M | |
| 7 | BAX | Baxter International United States · score 2.6 | 2% | 13 bn | 11 bn | -9.3% | 0.8 bn | 6.2% | 1.4% | Hospital products: infusion and clinical nutrition · Essential hospital supplies; sold its kidney care division (Vantive) to Carlyle | |
| 8 | SNN | Smith & Nephew United Kingdom · score 7.2 | 2% | 13 bn | 6.3 bn | 10.1% | 1.3 bn | 10.6% | 2.6% | Orthopedic implants, sports medicine and wound care · Orthopedics, sports medicine and wound care | |
| 9 | TFX | Teleflex United States · score 1.9 | 1% | 5.5 bn | 2.3 bn | -45.8% | 0.2 bn | 3.1% | 1.1% | Catheters, tubes and single-use medical devices · Single-use devices for surgery and critical care | |
| 10 | MMSI | MERIT MEDICAL SYSTEMS INC United States · score 5.6 | 1% | 5.4 bn | 1.6 bn | 9.2% | 0.2 bn | 3.8% | — | Medical devices for cardiology, radiology and oncology · Utah — revenue of $1.6bn | |
| 11 | HAE | HAEMONETICS CORP United States · score 5.4 | 1% | 5.4 bn | 1.4 bn | 7.1% | 0.3 bn | 5.4% | — | Medical technology for blood collection and processing · Massachusetts — revenue of $1.4bn | |
| 12 | ITGR | Integer Holdings Corp United States · score 4.7 | 1% | 4.3 bn | 1.8 bn | 7.0% | 0.1 bn | 2.6% | — | One of the largest medical device contract manufacturers · Texas — revenue of $1.8bn | |
| 13 | LIVN | LivaNova PLC United Kingdom · score 5.6 | 1% | 4.3 bn | 1.5 bn | 12.8% | 0.1 bn | 3.4% | — | Neuromodulation and cardiopulmonary equipment · United Kingdom — revenue of $1.5bn | |
| 14 | ICUI | ICU MEDICAL INC/DE United States · score 4.1 | 1% | 4.0 bn | 2.2 bn | 2.1% | 0.1 bn | 3.8% | — | Infusion pumps, catheters and IV solutions · California — revenue of $2.2bn | |
| 15 | PLSE | PULSE BIOSCIENCES, INC. United States · score 0.0 | 1% | 3.4 bn | 0.0 bn | -68x | -0.1 bn | -1.8% | — | Cell ablation with nanosecond electrical pulses · California — revenue of $1m | |
| 16 | TMDX | TransMedics Group, Inc. United States · score 5.7 | 0% | 2.5 bn | 0.7 bn | 22.7% | 0.1 bn | 3.2% | — | Medical technology for transporting and perfusing organs for transplant · Massachusetts — revenue of $668m | |
| 17 | UFPT | UFP TECHNOLOGIES INC United States · score 5.7 | 0% | 2.3 bn | 0.6 bn | 11.4% | 0.1 bn | 2.7% | — | Foam components and packaging for the medical market · Massachusetts — revenue of $632m | |
| 18 | AXGN | Axogen, Inc. United States · score 2.5 | 0% | 1.9 bn | 0.3 bn | -13.4% | 0.0 bn | 0.5% | — | Technologies for peripheral nerve regeneration and repair · Florida — revenue of $251m | |
| 19 | LMAT | LEMAITRE VASCULAR INC United States · score 6.3 | 0% | 1.9 bn | 0.3 bn | 26.3% | 0.1 bn | 3.9% | 1.1% | Medical devices and cryopreservation of human tissue · Massachusetts — revenue of $250m | |
| 20 | NVCR | NovoCure Ltd Jersey · score 0.1 | 0% | 1.7 bn | 0.7 bn | -21.2% | -0.0 bn | -1.5% | — | Oncology with electric fields to treat tumors · Jersey — revenue of $699m | |
| 21 | ESTA | ESTABLISHMENT LABS HOLDINGS INC. Costa Rica · score 0.0 | 0% | 1.7 bn | 0.3 bn | -15.8% | -0.0 bn | -2.4% | — | Medical technology for breast aesthetics and reconstruction · Costa Rica — revenue of $246m | |
| 22 | KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. United States · score 0.0 | 0% | 1.7 bn | 0.1 bn | -140.4% | -0.1 bn | -7.0% | — | Wearable defibrillator vests · Washington — revenue of $107m | |
| 23 | OMCL | OMNICELL, INC. United States · score 6.4 | 0% | 1.6 bn | 1.3 bn | 3.1% | 0.1 bn | 8.7% | — | Automated medication management for hospital pharmacies · Texas — revenue of $1.2bn | |
| 24 | CNMD | CONMED Corp United States · score 5.7 | 0% | 1.4 bn | 1.4 bn | 4.1% | 0.1 bn | 9.7% | 0.9% | Surgical devices for hospitals and surgery centers · Florida — revenue of $1.4bn | |
| 25 | DRTS | Alpha Tau Medical Ltd. Israel · score 0.1 | 0% | 1.1 bn | — | — | -0.0 bn | -1.5% | — | Alpha-radiation brachytherapy device for tumors, from Israel · Israel | |
| 26 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP United States · score 1.3 | 0% | 1.0 bn | 1.6 bn | -0.4% | 0.0 bn | 2.5% | — | Medical technology for tissue regeneration and neurosurgery · New Jersey — revenue of $1.6bn | |
| 27 | CBLL | Ceribell, Inc. United States · score 0.0 | 0% | 1.0 bn | 0.1 bn | -64.7% | -0.1 bn | -5.5% | — | Medical technology for diagnosing serious neurological conditions · California — revenue of $102m | |
| 28 | INMD | InMode Ltd. Israel · score 6.7 | 0% | 0.8 bn | 0.4 bn | 25.3% | 0.1 bn | 10.4% | — | Minimally invasive aesthetic equipment, from Israel · Israel — revenue of $370m | |
| 29 | MDXG | MIMEDX GROUP, INC. United States · score 6.2 | 0% | 0.6 bn | 0.4 bn | 1.8% | 0.1 bn | 7.2% | — | Regenerative products for wound healing · Georgia — revenue of $355m | |
| 30 | TCMD | TACTILE SYSTEMS TECHNOLOGY INC United States · score 6.2 | 0% | 0.5 bn | 0.3 bn | 7.1% | 0.0 bn | 5.2% | — | Medical devices for underserved chronic conditions · Minnesota — revenue of $350m | |
| 31 | ANGO | ANGIODYNAMICS INC United States · score 2.0 | 0% | 0.5 bn | 0.3 bn | -10.1% | 0.0 bn | 0.3% | — | Medical technology for cardiovascular disease and cancer · New York — revenue of $325m | |
| 32 | DCTH | DELCATH SYSTEMS, INC. United States · score 4.5 | 0% | 0.5 bn | 0.1 bn | 0.6% | 0.0 bn | 3.5% | — | Interventional oncology for liver tumors · New York — revenue of $95m | |
| 33 | BWAY | Brainsway Ltd. Israel · score 4.8 | 0% | 0.5 bn | 0.1 bn | 15.6% | 0.0 bn | 1.6% | — | Deep transcranial magnetic stimulation (Deep TMS) systems for depression, OCD and smoking addiction · Israel — revenue of $61m | |
| 34 | CERS | CERUS CORP United States · score 0.0 | 0% | 0.4 bn | 0.3 bn | -2.7% | 0.0 bn | -0.4% | — | INTERCEPT blood safety system · California — revenue of $249m | |
| 35 | NPCE | NeuroPace Inc United States · score 0.0 | 0% | 0.4 bn | 0.1 bn | -17.9% | -0.0 bn | -2.6% | — | Medical devices to reduce epileptic seizures · California — revenue of $107m | |
| 36 | RCEL | AVITA Medical, Inc. United States · score 0.0 | 0% | 0.4 bn | 0.1 bn | -57.0% | -0.0 bn | -6.1% | — | Advanced treatment of acute wounds · California — revenue of $76m | |
| 37 | INFU | InfuSystem Holdings, Inc United States · score 6.6 | 0% | 0.3 bn | 0.1 bn | 6.0% | 0.0 bn | 8.4% | — | Infusion services and equipment · Michigan — revenue of $143m | |
| 38 | SMTI | Sanara MedTech Inc. United States · score 0.8 | 0% | 0.3 bn | 0.1 bn | -29.2% | 0.0 bn | 1.5% | — | Medical technology to improve surgical outcomes · Texas — revenue of $110m | |
| 39 | MOBI | Mobia Medical, Inc. United States · score 5.1 | 0% | 0.3 bn | 0.1 bn | — | — | — | — | — | Medical devices for motor recovery after stroke · Texas — revenue of $45m |
| 40 | OBIO | Orchestra BioMed Holdings, Inc. United States · score 0.0 | 0% | 0.3 bn | 0.0 bn | -184.6% | -0.1 bn | -17.4% | — | Biomedical innovation partnered with major device makers · Pennsylvania — revenue of $32m | |
| 41 | PDEX | PRO DEX INC United States · score 5.5 | 0% | 0.2 bn | 0.1 bn | 17.6% | 0.0 bn | 3.7% | — | Surgical motors for orthopedic and craniomaxillofacial surgery · California — revenue of $78m | |
| 42 | TLSI | TriSalus Life Sciences, Inc. United States · score 0.0 | 0% | 0.2 bn | 0.1 bn | -62.6% | -0.0 bn | -10.7% | — | Drug delivery technology for solid tumors · Colorado — revenue of $45m | |
| 43 | UTMD | UTAH MEDICAL PRODUCTS INC United States · score 7.0 | 0% | 0.2 bn | 0.0 bn | 29.0% | 0.0 bn | 4.8% | 1.7% | Medical devices for obstetrics and neonatology · Utah — revenue of $36m | |
| 44 | SKIN | SkinHealth Systems Inc. United States · score 3.6 | 0% | 0.1 bn | 0.3 bn | -9.8% | 0.0 bn | 30.8% | — | Aesthetic skin equipment and treatments · California — revenue of $290m | |
| 45 | STIM | Neuronetics, Inc. United States · score 0.0 | 0% | 0.1 bn | 0.2 bn | -19.6% | -0.0 bn | -7.7% | — | Transcranial magnetic stimulation therapy · Pennsylvania — revenue of $155m | |
| 46 | OWLT | Owlet, Inc. United States · score 0.0 | 0% | 0.1 bn | 0.1 bn | -7.7% | -0.0 bn | -7.0% | — | Wearable pediatric health monitors for home use · Utah — revenue of $115m | |
| 47 | APYX | Apyx Medical Corp United States · score 0.0 | 0% | 0.1 bn | 0.1 bn | -14.8% | -0.0 bn | -10.8% | — | Surgical aesthetics with helium plasma technology · Florida — revenue of $58m | |
| 48 | KRMD | KORU Medical Systems, Inc. United States · score 2.0 | 0% | 0.1 bn | 0.1 bn | -4.0% | 0.0 bn | 0.6% | — | Large-volume subcutaneous infusion solutions · New Jersey — revenue of $45m | |
| 49 | ECOR | electroCore, Inc. United States · score 0.0 | 0% | 0.1 bn | 0.0 bn | -40.0% | -0.0 bn | -14.2% | — | Vagus nerve stimulation for pain and wellness · New Jersey — revenue of $37m | |
| 50 | NRXS | Neuraxis, INC United States · score 0.0 | 0% | 0.1 bn | 0.0 bn | -215.2% | -0.0 bn | -5.7% | — | Neuromodulation for gastrointestinal disorders · Indiana — revenue of $4m | |
| 51 | RNXT | RenovoRx, Inc. United States · score 0.0 | 0% | 0.1 bn | 0.0 bn | -621.7% | -0.0 bn | -22.8% | — | Targeted chemotherapy delivery with the RenovoCath catheter · California — revenue of $2m | |
| 52 | COCH | Envoy Medical, Inc. United States · score 0.0 | 0% | 0.1 bn | 0.0 bn | -113x | -0.0 bn | -43.0% | 3.6% | Medical technology for hearing loss · Minnesota | |
| 53 | ARAY | ACCURAY INC United States · score 0.0 | 0% | 0.0 bn | 0.4 bn | -12.2% | -0.0 bn | -76.9% | — | Radiation therapy: equipment, planning and imaging · Wisconsin — revenue of $402m | |
| 54 | TELA | TELA Bio, Inc. United States · score 0.0 | 0% | 0.0 bn | 0.1 bn | -51.5% | -0.0 bn | -72.7% | — | Medical technology for soft tissue reconstruction · Pennsylvania — revenue of $80m | |
| 55 | CVRX | CVRx, Inc. United States · score 0.0 | 0% | 0.0 bn | 0.1 bn | -84.9% | -0.0 bn | -114.0% | — | Minimally invasive neuromodulation for cardiovascular disease · Minnesota — revenue of $61m | |
| 56 | MYO | MYOMO, INC. United States · score 0.0 | 0% | 0.0 bn | 0.0 bn | -33.5% | -0.0 bn | -16.8% | — | Wearable medical robotics for neuromuscular disorders · Massachusetts — revenue of $43m | |
| 57 | SNWV | SANUWAVE Health, Inc. United States · score 4.5 | 0% | 0.0 bn | 0.0 bn | 34.7% | 0.0 bn | 10.2% | — | Energy-based medical devices for wound care · Minnesota — revenue of $44m | |
| 58 | CTSO | Cytosorbents Corp United States · score 0.0 | 0% | 0.0 bn | 0.0 bn | -49.0% | -0.0 bn | -59.6% | — | Blood purification in the ICU and cardiac surgery · New Jersey — revenue of $37m | |
| 59 | POCI | PRECISION OPTICS CORPORATION, INC. United States · score 0.3 | 0% | 0.0 bn | 0.0 bn | -11.5% | 0.0 bn | -4.2% | — | Optical instruments for medical devices and defense, since 1982 · Massachusetts — revenue of $32m | |
| 60 | RVP | RETRACTABLE TECHNOLOGIES INC United States · score 0.2 | 0% | 0.0 bn | 0.0 bn | -9.9% | -0.0 bn | -33.1% | — | Retractable safety syringes · Texas — revenue of $34m | |
| 61 | SRTS | Sensus Healthcare, Inc. United States · score 0.0 | 0% | 0.0 bn | 0.0 bn | -88.5% | -0.0 bn | -15.4% | — | Superficial radiation therapy for skin cancer · Florida — revenue of $18m | |
| 62 | NEPH | NEPHROS INC United States · score 2.3 | 0% | 0.0 bn | 0.0 bn | 8.4% | 0.0 bn | -1.8% | — | High-performance water filtration for medical use · New Jersey — revenue of $21m | |
| 63 | BDMD | Baird Medical Investment Holdings Ltd China · score 4.0 | 0% | 0.0 bn | 0.0 bn | -65.1% | 0.0 bn | 22.9% | — | Microwave ablation equipment for tumors, from China · China — revenue of $24m | |
| 64 | LFWD | Lifeward Ltd. United States · score 0.0 | 0% | 0.0 bn | 0.0 bn | -141.3% | -0.0 bn | -101.8% | — | Exoskeletons and physical rehabilitation devices · Massachusetts — revenue of $22m | |
| 65 | SNOA | Sonoma Pharmaceuticals, Inc. United States · score 0.0 | 0% | 0.0 bn | 0.0 bn | -10.3% | 0.0 bn | -49.2% | — | Hypochlorous acid products for wounds, eyes and disinfection · Colorado — revenue of $22m | |
| 66 | ELUT | ELUTIA INC. United States · score 1.2 | 0% | 0.0 bn | 0.0 bn | 426.9% | -0.1 bn | -127.5% | — | Drug-eluting biomatrices for surgical reconstruction · Maryland — revenue of $12m | |
| 67 | MLSS | MILESTONE SCIENTIFIC INC. United States · score 0.1 | 0% | 0.0 bn | 0.0 bn | -44.0% | 0.0 bn | -2.2% | — | Computer-controlled painless injection for dentistry and medicine · New Jersey — revenue of $9m | |
| 68 | NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp United States · score 0.0 | 0% | 0.0 bn | 0.0 bn | -78.6% | -0.0 bn | -78.7% | — | Brain diagnostic and ablation electrodes for epilepsy · Minnesota — revenue of $9m | |
| 69 | NXGL | NEXGEL, INC. United States · score 0.0 | 0% | 0.0 bn | 0.0 bn | -51.3% | 0.0 bn | -116.9% | — | Hydrogels for wound care, diagnostics and cosmetics · Pennsylvania — revenue of $12m | |
| 70 | NUWE | Nuwellis, Inc. United States · score 0.0 | 0% | 0.0 bn | 0.0 bn | -125.6% | -0.0 bn | -629.4% | — | Ultrafiltration for fluid management in cardiorenal patients · Minnesota — revenue of $9m | |
| 71 | PAVM | PAVmed Inc. United States · score 0.0 | 0% | 0.0 bn | 0.0 bn | -108x | -0.0 bn | -43.2% | — | Medical technologies developed through subsidiaries · New York | |
| 72 | ICU | SeaStar Medical Holding Corp United States · score 0.0 | 0% | 0.0 bn | 0.0 bn | -795.5% | -0.0 bn | -83.5% | — | Commercial-stage treatments for critically ill patients · Colorado — revenue of $2m | |
| 73 | HSCS | HeartSciences Inc. United States · score 0.0 | 0% | 0.0 bn | 0.0 bn | -2052x | -0.0 bn | -46.2% | — | AI-powered electrocardiogram technology · Texas | |
| 74 | FEMY | FEMASYS INC United States · score 0.0 | 0% | 0.0 bn | 0.0 bn | -511.9% | -0.0 bn | -131.9% | — | Therapeutic and diagnostic products for women's health · Georgia — revenue of $2m | |
| 75 | AEMD | AETHLON MEDICAL INC United States · score 0.0 | 0% | 0.0 bn | — | — | -0.0 bn | -86.7% | — | Hemopurifier blood filter for solid tumors and viruses · California | |
| 76 | NVNO | enVVeno Medical Corp United States · score 0.0 | 0% | 0.0 bn | — | — | -0.0 bn | -276.0% | — | Bioprosthetic devices for venous disease · California | |
| 77 | PFSA | Profusa, Inc. United States · score 0.3 | 0% | 0.0 bn | — | — | -0.0 bn | -41x | — | Implantable biosensors, approved in Europe · New York | |
| 78 | ZJYL | Jin Medical International Ltd. China · score 1.4 | — | — | 0.0 bn | 5.9% | -0.0 bn | — | — | Wheelchairs and mobility products, from China · China — revenue of $20m | |
| 79 | WOK | WORK Medical Technology Group LTD China · score 1.4 | — | — | 0.0 bn | -41.9% | -0.0 bn | — | — | Disposable medical devices, from China · China — revenue of $11m | |
| 80 | IVF | INVO Fertility, Inc. United States · score 0.9 | — | — | 0.0 bn | -92.3% | 0.0 bn | — | — | Services and technology for assisted reproduction · Florida — revenue of $8m | |
| 81 | ICCM | IceCure Medical Ltd. Israel · score 0.7 | — | — | 0.0 bn | -427.7% | -0.0 bn | — | — | Cryoablation of breast tumors, from Israel · Israel — revenue of $4m | |
| 82 | ITOC | iTonic Holdings Ltd China · score 0.9 | — | — | 0.0 bn | -16x | 0.0 bn | — | — | Brachytherapy treatment planning systems using radioactive sources, in China · China | |
| 83 | VBIO | Valion Bio, Inc. United States · score 0.1 | — | — | 0.0 bn | -41x | -0.0 bn | — | — | Bioelectronic device for sinusitis and migraine · Texas | |
| 84 | NXL | Nexalin Technology, Inc. United States · score 0.4 | — | — | 0.0 bn | -41x | -0.0 bn | — | — | Neurostimulation for mental health · Texas | |
| 85 | CUPR | Cuprina Holdings (Cayman) LTD Singapore · score 1.2 | — | — | 0.0 bn | -93x | -0.0 bn | — | — | Wound-healing biomedicine, from Singapore · Singapore | |
| 86 | AMIX | Autonomix Medical, Inc. United States · score 2.8 | — | — | 0.0 bn | — | -0.0 bn | — | — | Medical devices for nervous system sensing and treatment · Texas | |
| 87 | PLRZ | Polyrizon Ltd. Israel · score 1.2 | — | — | — | — | 0.0 bn | — | — | Nasal barrier hydrogels, from Israel · Israel |
Other industries in the same sector
- Sector overview
- Large-cap pharmaceuticals 9 companies
- Biotechnology 57 companies
- European pharmaceuticals 5 companies
- Lab tools and consumables 37 companies
- Health insurance and services 17 companies
- Specialty pharmaceuticals 77 companies
- Pharmaceutical distribution 7 companies
- Clinical-stage pharmaceuticals 251 companies
- Robotic surgery and advanced medtech 9 companies
- Hospitals 23 companies
- Emerging biotech 5 companies
- Molecular testing and advanced diagnostics 42 companies
and 22 industries more
- Vaccines and mRNA 14 companies
- Clinical-stage biotech 200 companies
- Generics and biosimilars 10 companies
- Animal health 7 companies
- Contract research (CRO) 10 companies
- Consumer health (OTC) 4 companies
- Healthcare software 18 companies
- Rehabilitation and home care 15 companies
- Genomics and sequencing 9 companies
- Structural heart 8 companies
- Ophthalmology 12 companies
- Medical imaging and hospital equipment 16 companies
- Diagnostic labs 6 companies
- Medical and dental supply distribution 3 companies
- Diabetes monitoring 9 companies
- Pharmaceutical royalties 5 companies
- Respiratory and sleep therapy 9 companies
- Orthopedic implants 17 companies
- Dialysis 3 companies
- Telehealth and digital health 12 companies
- Dental 4 companies
- Medical and recreational cannabis 16 companies
What this is. A catalogue, not a guide. Every industry with stocks listed on the NYSE or NASDAQ, the companies contending for its leadership, what each one does according to its own annual report, and the balance sheet it filed with the SEC.
The score runs from 0 to 10 and compares each company with every other one in the almanac on cash generation, profitability, debt, dividends and consistency over the last five years. The higher it is, the better the company fares in that comparison. Curious how much each part weighs? Ask at the bottom of the page.
The score runs from 0 to 10 and compares each company with every other one in the almanac on cash generation, profitability, debt, dividends and consistency over the last five years. The higher it is, the better the company fares in that comparison. Curious how much each part weighs? Ask at the bottom of the page.